Proactive Investors - Run By Investors For Investors

Medical Cannabis Payment Solutions to accept bitcoin for legal pot purchases using its Green app

“The ability to process bitcoin will make us that much more attractive to marijuana establishments and, perhaps more importantly, their clients,” said CEO Jeremy Roberts
a cannabis plant
Bitcoin goes to pot

Medical Cannabis Payment Solutions (OTC:REFDG) will soon accept bitcoin on its payment-processing platform that services legal marijuana sellers.

The Nevada-based company already processes transactions in US currency nationwide via a payment-processing app called Green. By adding the cryptocurrency to the platform, the company said it hopes to rapidly become “bitcoin-acceptable.”

US credit card companies, such as Visa Inc. (NYSE:V) and Mastercard  Inc. (NYSE:MA) decline to process transactions by state-approved merchants of recreational and medical marijuana, and banks will not accept deposits from pot sellers, even in states where it’s been legalized.

“Traditional banking systems do not allow state-sanctioned marijuana to access their payment systems,” said Jeremy Roberts, CEO of Medical Cannabis Payment Solutions, in a statement. “The feedback we have received indicates that the opportunity is bigger than just cashless electronic payments in US currency.”

Companies of all stripes have been slowly adopting bitcoin payments as the price of the cryptocurrency recently reached mania levels. There’s also been a push among banks and other traditional financial institutions to integrate blockchain the underlying technology behind bitcoin, as a secure option in digital transactions.

“Our security, regulatory compliance and pricing give us a huge competitive advantage,” Roberts said.  “The ability to process bitcoin will make us that much more attractive to marijuana establishments and, perhaps more importantly, their clients.”

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full APH profile View Profile

Aphria Timeline

Related Articles

cannabis leaf and green tablets
October 30 2018
The company will now proceed with stage II of the human clinical trial.
A marijuana plant
Fri
The company is bullish with 10 US states and Canada having legalized recreational marijuana
The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 31 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use